Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 30 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 7 Carcinoma, Renal Cell 6 Carcinoma, Hepatocellular 6 Lung Neoplasms 5 Ovarian Neoplasms 4 Colorectal Cancer Metastatic 3 Colonic Neoplasms 3 Adenocarcinoma of Lung 3 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Financial Stress 2 Brain Neoplasms 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Unresectable Hepatocellular Carcinoma 1 Surgical Wound Infection 1 Non-Squamous Non-Small Cell Lung Cancer 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 NSCLC 1 Melanoma 1 Kidney Neoplasms 1 Hypertension 1 Hemorrhage 1 Glioblastoma 1 Feasibility 1

Interventions

pembrolizumab 1 osimertinib 1 icotinib 1 dacomitinib 1 camrelizumab 1 Radiofrequency Ablation 1 Microphysiological Systems 1 Liquid Biopsy 1 Gefitinib 1 Erlotinib Hydrochloride 1 Bevacizumab 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × NSCLC × Bevacizumab × Clear all

NCT04575415 2020-10-20

BELLA

Guangdong Association of Clinical Trials

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡